CONMED Free Cash Flow 2012-2026 | CNMD
CONMED free cash flow from 2012 to 2026. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| CONMED Annual Free Cash Flow | |
|---|---|
| 2024 | 153.88 |
| 2023 | 106.32 |
| 2022 | 11.58 |
| 2021 | 96.90 |
| 2020 | 51.52 |
| 2019 | 75.07 |
| 2018 | 58.19 |
| 2017 | 52.72 |
| 2016 | 25.13 |
| 2015 | 35.91 |
| 2014 | 49.77 |
| 2013 | 62.50 |
| 2012 | 73.67 |
| 2011 | 85.44 |
| CONMED Quarterly Free Cash Flow | |
|---|---|
| 2025-09-30 | 109.66 |
| 2025-06-30 | 61.16 |
| 2025-03-31 | 37.76 |
| 2024-12-31 | 153.88 |
| 2024-09-30 | 114.59 |
| 2024-06-30 | 66.80 |
| 2024-03-31 | 27.09 |
| 2023-12-31 | 106.32 |
| 2023-09-30 | 54.78 |
| 2023-06-30 | 14.04 |
| 2023-03-31 | -8.10 |
| 2022-12-31 | 11.58 |
| 2022-09-30 | 28.85 |
| 2022-06-30 | 9.67 |
| 2022-03-31 | -3.36 |
| 2021-12-31 | 96.90 |
| 2021-09-30 | 66.31 |
| 2021-06-30 | 50.52 |
| 2021-03-31 | 19.24 |
| 2020-12-31 | 51.52 |
| 2020-09-30 | 34.52 |
| 2020-06-30 | 2.68 |
| 2020-03-31 | 0.90 |
| 2019-12-31 | 75.07 |
| 2019-09-30 | 40.38 |
| 2019-06-30 | 8.65 |
| 2019-03-31 | -7.94 |
| 2018-12-31 | 58.19 |
| 2018-09-30 | 38.25 |
| 2018-06-30 | 38.36 |
| 2018-03-31 | 21.24 |
| 2017-12-31 | 52.72 |
| 2017-09-30 | 35.52 |
| 2017-06-30 | 25.80 |
| 2017-03-31 | 12.71 |
| 2016-12-31 | 25.13 |
| 2016-09-30 | 15.75 |
| 2016-06-30 | -6.24 |
| 2016-03-31 | -19.35 |
| 2015-12-31 | 35.91 |
| 2015-09-30 | 27.24 |
| 2015-06-30 | 17.27 |
| 2015-03-31 | 10.75 |
| 2014-12-31 | 49.77 |
| 2014-09-30 | 27.28 |
| 2014-06-30 | 16.27 |
| 2014-03-31 | 12.96 |
| 2013-12-31 | 62.50 |
| 2013-09-30 | 40.09 |
| 2013-06-30 | 14.95 |
| 2013-03-31 | 1.34 |
| 2012-12-31 | 73.67 |
| 2012-09-30 | 45.29 |
| 2012-06-30 | 21.68 |
| 2012-03-31 | 1.21 |
| 2011-12-31 | 85.44 |
| 2011-09-30 | 64.04 |
| 2011-06-30 | 31.65 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $1.107B | $1.375B |
| CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |